Dinney CPN - Search Results

1

TCF21 Promotes Luminal-Like Differentiation and Suppresses Metastasis in Bladder Cancer.

Mokkapati S, Porten SP, Narayan VM, Lim AH, Jayaratna IS, Roth B, Cheng T, Navai N, Wszolek M, Melquist J, Manyam G, Choi W, Broom B, Pretzsch S, Czerniak B, McConkey DJ, Dinney CPN. Mokkapati S, et al. Among authors: dinney cpn. Mol Cancer Res. 2020 Jun;18(6):811-821. doi: 10.1158/1541-7786.MCR-19-0766. Epub 2020 Mar 2. Mol Cancer Res. 2020. PMID: 32122956

2

The relationship of local control to distant metastasis in muscle invasive bladder cancer.

Pollack A, Zagars GK, Cole CJ, Dinney CP, Swanson DA, Grossman HB. Pollack A, et al. J Urol. 1995 Dec;154(6):2059-63; discussion 2063-4. J Urol. 1995. PMID: 7500458

3

Preoperative radiotherapy for muscle-invasive bladder carcinoma. Long term follow-up and prognostic factors for 338 patients.

Pollack A, Zagars GK, Dinney CP, Swanson DA, von Eschenbach AC. Pollack A, et al. Cancer. 1994 Nov 15;74(10):2819-27. doi: 10.1002/1097-0142(19941115)74:10<2819::aid-cncr2820741013>3.0.co;2-l. Cancer. 1994. PMID: 7954243 Clinical Trial.

4

Prognostic value of p53 in muscle-invasive bladder cancer treated with preoperative radiotherapy.

Wu CS, Pollack A, Czerniak B, Chyle V, Zagars GK, Dinney CP, Hu SX, Benedict WF. Wu CS, et al. Urology. 1996 Mar;47(3):305-10. doi: 10.1016/s0090-4295(99)80443-9. Urology. 1996. PMID: 8633392 Clinical Trial.

5

Suppression of human bladder cancer growth by increased expression of C-CAM1 gene in an orthotopic model.

Kleinerman DI, Dinney CP, Zhang WW, Lin SH, Van NT, Hsieh JT. Kleinerman DI, et al. Cancer Res. 1996 Aug 1;56(15):3431-5. Cancer Res. 1996. PMID: 8758907

6

Retinoblastoma protein expression and radiation response in muscle-invasive bladder cancer.

Pollack A, Czerniak B, Zagars GK, Hu SX, Wu CS, Dinney CP, Chyle V, Benedict WF. Pollack A, et al. Int J Radiat Oncol Biol Phys. 1997 Oct 1;39(3):687-95. doi: 10.1016/s0360-3016(97)00147-8. Int J Radiat Oncol Biol Phys. 1997. PMID: 9336151

7

Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration.

Dinney CP, Bielenberg DR, Perrotte P, Reich R, Eve BY, Bucana CD, Fidler IJ. Dinney CP, et al. Cancer Res. 1998 Feb 15;58(4):808-14. Cancer Res. 1998. PMID: 9485039

8

p53 and RB expression predict progression in T1 bladder cancer.

Grossman HB, Liebert M, Antelo M, Dinney CP, Hu SX, Palmer JL, Benedict WF. Grossman HB, et al. Clin Cancer Res. 1998 Apr;4(4):829-34. Clin Cancer Res. 1998. PMID: 9563875

9

Therapy of human transitional cell carcinoma of the bladder by oral administration of the epidermal growth factor receptor protein tyrosine kinase inhibitor 4,5-dianilinophthalimide.

Dinney CP, Parker C, Dong Z, Fan D, Eve BY, Bucana C, Radinsky R. Dinney CP, et al. Clin Cancer Res. 1997 Feb;3(2):161-8. Clin Cancer Res. 1997. PMID: 9815668

10

Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta.

Dong Z, Greene G, Pettaway C, Dinney CP, Eue I, Lu W, Bucana CD, Balbay MD, Bielenberg D, Fidler IJ. Dong Z, et al. Cancer Res. 1999 Feb 15;59(4):872-9. Cancer Res. 1999. PMID: 10029078

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

457 results

Search Page

Filters